Brind.
  1. The European Society of Cardiology Congress was held in Madrid, Spain.

Cytokinetics presented study results at the European Society of Cardiology Congress in Madrid, Spain.

6 reports, 5 independent Updated Jul 7
Gone quiet Reached 4 outlets in its first 24 hours
Reports
6
Developments
1
Repetition
83%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 5 independent outlets

Cytokinetics presented study results at the European Society of Cardiology Congress in Madrid, Spain.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • manilatimes.net
  • ZacksCytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results Cytokinetics, Incorporated's (CYTK) shares surged 40.4% on Sept. 2, driven by positive results from a phase III study on cardiov
  • Insider MonkeyCytokinetics (CYTK) Rockets 40.45% as Aficamten Results Promising We recently published 10 Power Stocks Crushing Wall Street — 7 at All-Time Highs. Cytokinetics, Inc. (NASDAQ:CYTK) is one of the best
  • Clinical Trials ArenaESC 2025: study gives insight into OM and red cell distribution width On 30 August 2025, at the 75th European Society of Cardiology (ESC) conference held in Madrid, Spain, during an abstract session
  • GlobeNewswireCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 Positive Results from MAPLE-HCM to be Shared in Hot Line Presentation Late Breaking
  • GlobeNewswireCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 Hot Line Presentation of MAPLE-HCM to Elaborate on Positive Topline Results in Patie